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Rescue anti-emeticAbstract Objective: Many trials have been conducted with regard to the relative
benefits of prophylactic anti-emetic interventions given alone or in combination,
yet the results remain unknown. This study reviewed the efficacy of a single prophy-
lactic dose of dexamethasone on postoperative nausea or vomiting (PONV) after
abdominal hysterectomy.
Methods: In a prospective study of 100 women undergoing total abdominal hyster-
ectomy (TAH) under general anesthesia, the dexamethasone group (n = 50) received a
single dose (8 mg) immediately after the operation, and the saline group (n = 50)
received a dose of saline as a placebo, in addition to conventional management. The
incidence of nausea, vomiting, the need for an anti-emetic and patient satisfaction
with themanagement of PONVwere evaluated during the first 24 postoperative hours.
Results: The overall frequency of nausea during the initial postoperative 24 in the
dexamethasone and saline groups were 12% and 18%, respectively, and vomiting was
10% and 16%, respectively (P = 0.001). However, there was a lower need for a rescue
anti-emetic drugs in the dexamethasone group (18% vs 24%), but it was not statistically
significant (P = 0.06).
Conclusion: The results of this study indicate that a single prophylactic dose of
dexamethasone after an operation can reduce postoperative nausea and vomiting.
ª 2014 Ministry of Health, Saudi Arabia. Published by Elsevier Ltd. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/
by-nc-nd/4.0/).1. Introduction
Postoperative nausea and vomiting (PONV) is an
unpleasant and relatively common occurrence
176 L. Sekhavat et al.sequel of general anesthesia that may increase
morbidity, prolong hospital stay and can lead to
serious complications [1,2]. The overall incidence
of PONV in adults is 20%–30%; the incidence rate
in patients of high-risk groups can be as high as
70%–80% [3]. The incidence of postoperative nau-
sea or vomiting depends on numerous non-anes-
thetic factors, including the type of surgery,
duration of surgery, use of postoperative opioids,
age, smoking, history of motion sickness and previ-
ous postoperative nausea history [4,5].
The etiology and consequences of PONV are
complex when taking into consideration patients
medical- and surgery-related factors. A thorough
understanding of these factors is necessary for
the management of PONV [6]. The most common
drugs used for the treatment of PONV include
butyrophenones, benzamides, histamine receptor
antagonists, muscarinic receptor antagonists, and
5-HT3 (5-hydroxy tryptamine 3) receptor antago-
nists. Non- pharmacologic treatment methods,
such as acupuncture, electro-acupuncture, trans-
cutaneous electrical nerve stimulation (TENS),
and acupressure have also been studied for their
efficacy in the prevention of PONV [7]. There are
no completely effective anti-emetic agents for this
condition, but recommendations for treatment
strategies are separately available. The optimal
strategy for prevention and management of PONV
is still controversial. Even though many drugs have
been studied for the prevention of PONV, prophy-
laxis is not very effective, may be costly, and has
a potential risk of adverse drug reactions [8,9].
Tong J. Gan, et al. reported ‘‘reducing baseline
risk factors can significantly decrease the incidence
of PONV. Strategies recommended to reduce base-
line risk include: the avoidance of general anesthe-
sia by the use of regional anesthesia; preferential
use of propofol infusions; avoidance of nitrous
oxide; avoidance of volatile anesthetics; minimiza-
tion of peri-operative opioids and adequate hydra-
tion [10]’’.
Dexamethasone is a high-potency, long-acting
glucocorticoid with little mineralocorticoid effect,
with a biologic half-life of 36–72 h that has been
extensively used in the perioperative setting. Dexa-
methasone is a low-cost and effective anti-emetic
drug, with minimal side effects after a single-dose
administration [3]. Dexamethasone was first
reported to be an effective anti-emetic regimen
in patients receiving cancer chemotherapy [11].
Recently, studies showed that dexamethasone
can be effective in preventing PONV in adults and
children. Compared with other preventive medica-
tions, dexamethasone has equal or even betterefficacy in reducing the incidence of PONV and
has the advantages of low cost and longer effec-
tiveness as well. Although the action mechanism
of dexamethasone is hitherto not fully understood,
animal studies have confirmed that the vomiting
center in the brain stem plays a central role
[12–14].
The purpose of this study was to evaluate the
efficacy of a single prophylactic dose of dexameth-
asone treatment for reducing PONV in women
undergoing general anesthesia for abdominal
hysterectomy.
2. Methods
This prospective, double-blind, placebo-controlled
study was designed and conducted on 100 women
undergoing abdominal hysterectomy for various
indications. All patients were referred to Shahid
Sadoughi hospital in Yazd from June 2009 to Sep-
tember 2010. The adopted protocol was approved
by the hospital research and ethics committee
(Institutional Review Board) in accordance with
the Helsinki declaration. All women were inter-
viewed individually by the researcher. Written
informed consent was obtained from all the
patients.
Sample size estimations were based on the
results of a previous study, and assuming an a level
of 0.05 and ß error of 0.8, 44 patients were needed
per group to detect a 10 point difference on a
0–100 visual analog nausea scale score. To account
for possible loss to follow-up, it was decided to
include 50 patients per trial arm.
Women were excluded from the study if they
had a known allergy/hypersensitivity to dexameth-
asone, nausea or vomiting within 24 h before their
operation, had received an anti-emetic within 48 h
before surgery, or had any gastrointestinal
disorders (e.g., esophagitis, gastritis). Before entry
into the study, patients provided detailed medical
histories and demographic information.
All surgeries were performed under general
anesthesia. In this hospital, general anesthesia
was comprised of pre-medication of 2 mg midazo-
lam intravenous (IV) and induction anesthesia
fentanyl 2 lg/kg + propofol 2 mg/kg IV with venti-
lation of N2O - O2 (50–50) and infusion of propofol
100–200 mg/kg/min as maintenance anesthesia.
At the end of the surgery, the patients were ran-
domly allocated to either the administration of a
single dose of dexamethasone 8 mg IV (50 women)
or saline 2 mL IV (50 women) as a placebo, in addi-
tion to conventional management. Randomization
was performed with a computer-driven random
Dexamethasone and Nausea & vomiting 177number sequence and sealed in opaque envelopes.
Prior to each operation, the set was prepared with
identical syringes containing dexamethasone or
saline for injection with the purpose of maintaining
blindness in the study.
Following surgery, all women were transferred
to the post-anesthesia care unit (PACU) and stayed
there for around 2 h. Lactated Ringer (1000–
2000 mL) was used as fluid maintenance. Morphine
5 mg IV was used as pain rescue medication during
PACU stay and mefenamic acid 500 mg PO Q4H
hours was given as part of the standard post-oper-
ative pain procedures. Postoperatively, patients
were NPO for 12 h and were observed for 24 h. At
the discretion of the attending surgeon, feeding
was started on the first post-operative day with
clear liquid and solid food was started after bowel
function was established. During the observation
period, arterial blood pressure (BP), heart rate
(HR), and respiratory rate (RR) were monitored
every 4 h except when patients were sleeping. All
were given routine prophylactic antibiotics.
The frequencies of nausea and vomiting, the
intensity of nausea, and the proportions of patients
who requested rescue anti-emetic were recorded.
Nauseawas defined as a subjectively unpleasant sen-
sation associated with awareness of the urge to
vomit. Vomiting was defined as the forceful expul-
sion of gastric contents from the mouth. Also retch-
ing was recorded as an episode of vomiting. Nausea
was scored by using a linear scale from 0 to 10, with
0 representing no nausea and 10 representing nausea
‘‘as bad as it can be.’’ Rescue medication for severe
nausea (nausea for more than 30 min or at the
patients request to treat intolerable nausea) and
vomiting (more than one emetic episode in 15 min)
were treated according to the hospitals routine
(metoclopramide 10 mg IVPRNevery 8 h). The treat-
ment was repeated if necessary. The postoperative
nausea, vomiting and medications required were
evaluated and recorded by a second-year resident
and were collected every 4 h during the first 24 h
after surgery. The duration of hospital stay and the
incidence of side effects were recorded as well.
Patients were asked to rate their level of satis-
faction by using a scale from 0 to 10.
Analysis of data was performed with the SPSS
15.5 software. Statistical methods included Stu-
dents t-test, Fisher exact test and v2 test; p-values
less than 0.05 were considered as significant.
3. Results
One hundred women completed the study: 50
women received a single dose (8 mg) of dexameth-asone and 50 women received saline as a placebo in
addition to conventional management. Table 1
shows that there was no difference in the demo-
graphic and medical characteristics of both studied
groups. As a result of the study design, the two
study groups were also identical for indication of
hysterectomy.
Table 2 presents the frequencies of post-
operative nausea and vomiting. As shown in
Table 2, patients who received dexamethasone dif-
fered from those who received saline alone in total
frequency of nausea and vomiting (22% vs 34%,
P = 0.004) and in percentage of patients requiring
a rescue anti-emetic during the 24 h following sur-
gery, but it was not statistically significant (18% vs
24%, P = 0.06).
Patient satisfaction with dexamethasone was
higher than saline. Hospital stay was similar in both
groups, and adverse reactions were not seen in any
group.
4. Discussion
The results of this study showed that dexametha-
sone was effective in reducing the occurrence of
PONV after abdominal hysterectomy. The overall
incidence of PONV within the first 24 h after
surgery was 22% in the group who used dexameth-
asone and 34% in the saline group.
These findings are in accordance with recent
studies that showed dexamethasone can be effec-
tive in preventing PONV in adults and children.
Compared with other preventive medications,
dexamethasone has equal or even better efficacy
in reducing the incidence of PONV and has the
advantages of low cost and longer effectiveness
as well [12–16].
Tzeng et al. reported that the administration of
low dose dexamethasone (5 mg) was more effec-
tive than metoclopramide or saline in the preven-
tion of post-operative nausea and vomiting
associated with epidural morphine for post-
operative analgesia [14]. Their study was about
dexamethasones effect on reducing nausea and
vomiting in conjunction with morphine and epidu-
ral analgesia; they found that low dose dexameth-
asone was more effective than metoclopramide for
PONV for post-operative analgesia. On the other
hand, Liu and colleagues demonstrated that dexa-
methasone alone at doses of 5 mg and 2.5 mg are
as effective as 10 mg in reducing the incidence of
PONV after gynecologic surgery [17]. Although, El
hakim et al. believed that 8 mg is the minimum
dose of dexamethasone that effectively prevents
PONV [14].
Table 1 Patient demographics and operation characteristics.
Characteristics Dexamethasone group (n = 50) Saline group (n = 50) P value
Age (year) (Mean ± SD) 44 ± 5.6 43 ± 5.1 0.2
BMI (Mean ± SD) 23 ± 3.1 24 ± 4.5 0.08
Indication of Hysterectomy AUB [N(%)] 36 (72) 33 (66) 0.07
Others [N(%)] 14 (28) 17 (34)
Duration of operation (minute) (Mean ± SD) 87 ± 12 89 ± 10 0.09
Duration of hospital stay (day) (Median) 3 3 –
Table 2 Incidence of nausea and vomiting and requiring a rescue anti-emetic during 24 h after surgery.
Dexamethasone group (n = 50) Saline group (n = 50) P value
0–2 h after surgery [N (%)]
Nausea 0 (0) 1 (2) 0.009
Vomiting 0 (0) 0 (0) –
2–6 h after surgery [N (%)]
Nausea 2 (4) 3 (6) 0.005
Vomiting 1 (2) 2 (4) 0.006
6–12 h after surgery [N (%)]
Nausea 3 (6) 2 (4) 0.01
Vomiting 1 (2) 2 (4) 0.007
12–24 h after surgery [N (%)]
Nausea 1 (2) 3 (6) 0.001
Vomiting 3 (6) 4 (8) 0.004
Totally 11 (22) 17 (34) 0.004
Requiring rescue anti-emetic 9 (18) 12 (24) 0.06
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tic dose of dexamethasone is anti-emetic com-
pared with a placebo, but the best late
prophylaxis (after 24 h) of PONV is achieved by a
combining dexamethasone with ondansetron or
granisetron [18].
Dexamethasone is a glucocorticoid that pro-
duces a strong anti-emetic effect and, with its
strong anti-inflammatory action, has been shown
to decrease post-operative pain. This is the reason
for patient satisfaction. In the present study,
patient satisfaction with dexamethasone was
higher than saline.
In the present study, no side effects related to
the use of dexamethasone and saline were noted.
Long-term corticosteroid therapy may have signifi-
cant morbidity, such as an increased risk of infec-
tion, delayed wound healing, glucose intolerance,
and adrenal suppression. However, side effects
from brief (24 h) corticosteroid treatment have
been rare [2].
Cost is an ever-increasing concern in todays
healthcare system [8]. Dexamethasone is a rela-
tively inexpensive drug in Iran. Dexamethasone8 mg costs $0.38 US, whereas commonly used
anti-emetic metoclopramide 10 mg cost $0.49 US.
Further studies with more patients and longer
follow-up are indicated to show side effects of
dexamethasone. Also, further studies with differ-
ent doses of dexamethasone must be accomplished
to obtain the minimum dose of dexamethasone
that is effective in preventing PONV.
5. Conclusion
Results suggest that prophylactic administration of
dexamethasone 8 mg can reduce the post-opera-
tive frequency of PONV in women undergoing
abdominal total hysterectomy.
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